Internal Medicine, Endocrinology, Diabetes, & Metabolism · Milford, CT
NPI
1598880031
Since 2007
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
2068 Bridgeport Ave
Milford, CT, 06460
Phone (203) 701-6787
Groups this clinician bills Medicare through
Medicare paid, 2024
$47K
628 services
Medicare patients, 2024
301
Average age 76
Drug cost, 2024
$2.9M
4,281 prescriptions
Company payments, 2025
$3,151
From 29 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Susan M Wang was code 99214 (office e&m - established), 323 times for 189 patients. In total Susan M Wang billed 628 services in 11 codes, and Medicare paid $47K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-12-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 323 | 189 | $92.21 | $30K |
| 99213 Office E&M - Established | Office | 173 | 135 | $66.76 | $12K |
| 95251 Test - Miscellaneous | Office | 47 | 31 | $26.30 | $1,236 |
| 99215 Office E&M - Established | Office | 19 | 14 | $136.49 | $2,593 |
By year: 2022 $66K for 783 services; 2023 $62K for 798 services; 2024 $47K for 628 services.
Medicare prescription drug claims, 2024
In 2024, the drug Susan M Wang prescribed most often to Medicare patients was Levothyroxine Sodium, with 501 prescriptions and refills. In total Susan M Wang wrote 4,281 Medicare prescriptions that cost $2.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 501 | 1,395 | 138 | $5,043 |
| Ozempic Semaglutide | 371 | 646 | 79 | $633K |
| Metformin Hcl Generic | 230 | 673 | 76 | $1,716 |
| Jardiance Empagliflozin | 224 | 495 | 59 | $292K |
| Synthroid Levothyroxine Sodium | 221 | 573 | 55 | $22K |
| Trulicity Dulaglutide | 155 | 307 | 40 | $307K |
| Mounjaro Tirzepatide | 152 | 204 | 33 | $219K |
| Metformin Hcl Er Metformin Hcl | 122 | 352 | 40 | $1,148 |
| Levoxyl Levothyroxine Sodium | 102 | 271 | 24 | $2,818 |
| Alendronate Sodium Generic | 101 | 271 | 35 | $1,064 |
| Methimazole Generic | 92 | 250 | 30 | $859 |
| Farxiga Dapagliflozin Propanediol | 87 | 193 | 24 | $110K |
| Tresiba Flextouch U-200 Insulin Degludec | 68 | 175 | 22 | $88K |
| Liothyronine Sodium Generic | 60 | 162 | 17 | $2,795 |
| Atorvastatin Calcium Generic | 58 | 170 | 19 | $309 |
Brand drugs: 2,273 claims; generic drugs: 1,738 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Susan M Wang $3,151 ($3,151 in general payments such as food, travel and fees) from 29 companies. The largest payer was Amgen Inc. with $469.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 12 | $469 |
| Lilly USA, LLC LLY | 13 | $380 |
| Novo Nordisk Inc NVO | 14 | $266 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 12 | $252 |
| Ascendis Pharma Endocrinology Inc ASND | 10 | $225 |
| Mannkind Corporation MNKD | 7 | $178 |
| Insulet Corporation PODD | 6 | $154 |
| Currax Pharmaceuticals LLC | 11 | $140 |
| ARS Pharmaceuticals Operations, Inc. SPRY | 1 | $125 |
| CeQur Corporation | 1 | $108 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.